Microbot Medical (MBOT) Non-Current Deffered Revenue (2010 - 2016)

Microbot Medical has reported Non-Current Deffered Revenue for 7 years, with the latest figure at $16639.0 in Q3 2016.

• For the quarter ending Q3 2016, Non-Current Deffered Revenue fell 99.0% year-over-year to $16639.0; the trailing twelve-month figure through Sep 2016 stood at $16639.0 (down 99.0% YoY), and the FY2015 full-year result was $29258.0, changed N/A from the prior year.
• Non-Current Deffered Revenue for Q3 2016 stood at $16639.0, down from $20845.0 in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $1.8 million in Q3 2013, with the low at $16639.0 in Q3 2016.
• Historically, Non-Current Deffered Revenue has averaged $896780.6 across 5 years, with a median of $1.4 million in 2012.
• Annual changes were most pronounced in 2015 — Non-Current Deffered Revenue surged 2814.08% — and 2016, when it slumped 99.0%.
• Microbot Medical's Non-Current Deffered Revenue stood at $79736.0 in 2012, then surged by 2146.09% to $1.8 million in 2013, then dropped by 3.17% to $1.7 million in 2014, then slumped by 98.31% to $29258.0 in 2015, then plunged by 43.13% to $16639.0 in 2016.
• The last three Non-Current Deffered Revenue figures came in at $16639.0 (Q3 2016), $20845.0 (Q2 2016), and $1.6 million (Q1 2016), per Business Quant data.